Traws Pharma, Inc. — Director's Dealing 2016

Jun 30, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2016-06-30

Reporting Person: Maniar Manoj (SVP - Product Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-30	Common Stock	M	50	$6.50	Acquired	50	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-30	Stock Option (right to buy)	$6.50	M	50	Disposed	2026-01-26	Common Stock (50)	Direct